Loading…
Based on limited metadata without access to the full warning letter text, the FDA issued this warning to Mushroom Revival, Inc., a company marketing drug products, on December 1, 2020. While the specific nature of the violations cannot be determined from the available metadata, the warning fell under FDA's drug product regulatory authority. Additional details regarding the particular compliance issues would require review of the complete warning letter document.